1 |
GlaxoSmithKline
|
1041 |
Registration: 15%
Summary results: 14%
Clinical study reports: 10%
Individual patient data: 14%
|
2 |
LEO Pharma
|
1030 |
Registration: 10%
Summary results: 19%
Clinical study reports: 13%
Individual patient data: 10%
|
3 |
Takeda Pharmaceuticals, Inc.
|
969 |
Registration: 16%
Summary results: 16%
Clinical study reports: 8%
Individual patient data: 10%
|
4 |
Pfizer Inc
|
892 |
Registration: 16%
Summary results: 8%
Clinical study reports: 12%
Individual patient data: 9%
|
5 |
Novartis Pharmaceuticals Corporation
|
885 |
Registration: 17%
Summary results: 18%
Clinical study reports: 6%
Individual patient data: 4%
|
6 |
Novo Nordisk A/S
|
867 |
Registration: 16%
Summary results: 9%
Clinical study reports: 9%
Individual patient data: 10%
|
7 |
Boehringer Ingelheim
|
819 |
Registration: 17%
Summary results: 11%
Clinical study reports: 8%
Individual patient data: 5%
|
8 |
Amgen Inc
|
704 |
Registration: 13%
Summary results: 14%
Clinical study reports: 5%
Individual patient data: 3%
|
9 |
Merck & Co.
|
676 |
Registration: 13%
Summary results: 6%
Clinical study reports: 7%
Individual patient data: 8%
|
10 |
AbbVie
|
658 |
Registration: 15%
Summary results: 7%
Clinical study reports: 2%
Individual patient data: 10%
|
11 |
Bayer HealthCare LLC
|
632 |
Registration: 15%
Summary results: 7%
Clinical study reports: 6%
Individual patient data: 4%
|
12 |
Eli Lilly and Company
|
629 |
Registration: 11%
Summary results: 7%
Clinical study reports: 7%
Individual patient data: 7%
|
13 |
Bristol-Myers Squibb Company
|
626 |
Registration: 10%
Summary results: 6%
Clinical study reports: 7%
Individual patient data: 9%
|
14 |
Merck KGaA & Merck (EMD) Serono
|
612 |
Registration: 11%
Summary results: 7%
Clinical study reports: 6%
Individual patient data: 7%
|
15 |
Johnson & Johnson
|
588 |
Registration: 14%
Summary results: 4%
Clinical study reports: 5%
Individual patient data: 6%
|
16 |
Astellas Pharma
|
574 |
Registration: 10%
Summary results: 4%
Clinical study reports: 6%
Individual patient data: 8%
|
17 |
Otsuka Pharmaceutical Co., Ltd
|
518 |
Registration: 10%
Summary results: 8%
Clinical study reports: 1%
Individual patient data: 7%
|
18 |
AstraZeneca Pharmaceuticals LP
|
513 |
Registration: 12%
Summary results: 9%
Clinical study reports: 0%
Individual patient data: 4%
|
19 |
Daiichi Sankyo, Inc
|
511 |
Registration: 10%
Summary results: 3%
Clinical study reports: 6%
Individual patient data: 7%
|
20 |
UCB
|
509 |
Registration: 14%
Summary results: 7%
Clinical study reports: 1%
Individual patient data: 3%
|
21 |
Roche
|
507 |
Registration: 0%
Summary results: 9%
Clinical study reports: 11%
Individual patient data: 5%
|
22 |
Eisai Inc.
|
491 |
Registration: 10%
Summary results: 2%
Clinical study reports: 5%
Individual patient data: 7%
|
23 |
Biogen
|
479 |
Registration: 10%
Summary results: 5%
Clinical study reports: 6%
Individual patient data: 4%
|
24 |
Ipsen
|
468 |
Registration: 14%
Summary results: 9%
Clinical study reports: 0%
Individual patient data: 0%
|
25 |
Sanofi
|
464 |
Registration: 10%
Summary results: 4%
Clinical study reports: 6%
Individual patient data: 4%
|
26 |
Lundbeck Inc.
|
447 |
Registration: 11%
Summary results: 2%
Clinical study reports: 6%
Individual patient data: 4%
|
27 |
Almirall
|
413 |
Registration: 14%
Summary results: 6%
Clinical study reports: 0%
Individual patient data: 0%
|
28 |
Celgene Corporation
|
394 |
Registration: 10%
Summary results: 0%
Clinical study reports: 6%
Individual patient data: 4%
|
29 |
PhRMA IFPMA EFPIA JPMA 2005 Joint Position on the Disclosure of Clinical TrialInformation via Clinical Trial Registries and Databases
|
343 |
Registration: 14%
Summary results: 3%
Clinical study reports: 0%
Individual patient data: 0%
|
30 |
PhRMA IFPMA EFPIA JPMA 2009 update to 2005 Joint Position on the Disclosure of Clinical TrialInformation via Clinical Trial Registries and Databases"
|
301 |
Registration: 12%
Summary results: 3%
Clinical study reports: 0%
Individual patient data: 0%
|
31 |
Orion Pharma
|
300 |
Registration: 10%
Summary results: 2%
Clinical study reports: 0%
Individual patient data: 3%
|
32 |
Servier
|
296 |
Registration: 15%
Summary results: 0%
Clinical study reports: 0%
Individual patient data: 0%
|
33 |
PhRMA "Principles on conduct of clinical trials, communication of clinical trial results." (Updated Dec 2014)
|
275 |
Registration: 10%
Summary results: 4%
Clinical study reports: 0%
Individual patient data: 0%
|
34 |
Menarini
|
263 |
Registration: 10%
Summary results: 3%
Clinical study reports: 0%
Individual patient data: 0%
|
35 |
Grunenthal
|
234 |
Registration: 0%
Summary results: 0%
Clinical study reports: 5%
Individual patient data: 7%
|
36 |
ViiV Healthcare
|
225 |
Registration: 0%
Summary results: 0%
Clinical study reports: 5%
Individual patient data: 6%
|
37 |
EFPIA/PhRMA "Principles for responsible clinical trial data sharing", 2013
|
176 |
Registration: 0%
Summary results: 0%
Clinical study reports: 5%
Individual patient data: 3%
|
38 |
Purdue Pharma L.P.
|
63 |
Registration: 0%
Summary results: 0%
Clinical study reports: 0%
Individual patient data: 3%
|
39 |
Medtronic
|
38 |
Registration: 0%
Summary results: 2%
Clinical study reports: 0%
Individual patient data: 0%
|
40 |
Abbott
|
0 |
Registration: 0%
Summary results: 0%
Clinical study reports: 0%
Individual patient data: 0%
|
41 |
Alkermes plc
|
0 |
Registration: 0%
Summary results: 0%
Clinical study reports: 0%
Individual patient data: 0%
|
42 |
Dainippon Sumitomo Pharma
|
0 |
Registration: 0%
Summary results: 0%
Clinical study reports: 0%
Individual patient data: 0%
|
43 |
Esteve
|
0 |
Registration: 0%
Summary results: 0%
Clinical study reports: 0%
Individual patient data: 0%
|
44 |
Gilead
|
0 |
Registration: 0%
Summary results: 0%
Clinical study reports: 0%
Individual patient data: 0%
|
45 |
Sigma-Tau Pharmaceuticals, Inc.
|
0 |
Registration: 0%
Summary results: 0%
Clinical study reports: 0%
Individual patient data: 0%
|
46 |
Valeant
|
0 |
Registration: 0%
Summary results: 0%
Clinical study reports: 0%
Individual patient data: 0%
|